HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/2/G288    most recent 00324.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Ramasamy, S. Articles by Eggo, M. C. Search for Related Content PubMed PubMed Citation Articles by Ramasamy, S. Articles by Eggo, M. C.

INFLAMMATION/IMMUNITY/MEDIATORS

Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation

¹Division of Medical Sciences, Department of Medicine, University of Birmingham; ²Department of Gastroenterology, Good Hope Hospital, Sutton Coldfield; and ³Department of Cellular Pathology, University Hospital NHS Trust, Queen Elizabeth Hospital, Birmingham, United Kingdom

Submitted 14 July 2005 ; accepted in final form 21 February 2006

H₂S is highly toxic and selectively inhibits butyrate oxidation in colonocytes. Ineffective detoxification may result in mucosal insult, inflammation, and ultimately in colorectal cancer (CRC). Rhodanese can detoxify H₂S and is comprised of two isoenzymes: thiosulfate sulfurtransferase (TST) and mercaptopyruvate sulfurtransferase (MST). Using specific antisera to discriminate TST from MST, we found that only TST could detoxify H₂S. In sections of normal colon, both enzymes were located on the luminal mucosal surface, and they were expressed in the colonocytes but not in the mucin-secreting goblet cells. Expression of both enzymes was focally lost in ulcerative colitis and markedly reduced in advanced colon cancer, the disease progression correlating with the decreased expression of MST and TST. In HT-29 cells, a human colon cancer cell line, TST activity and expression were significantly increased by butyrate and by histone deacetylase inhibition, agents that promote HT-29 cell differentiation. Sulfide (0.1 mM) also increased TST activity, but higher sulfide concentrations (0.3–3 mM) were toxic. Preincubation in butyrate to increase TST expression, decreased sensitivity of the cells to sulfide toxicity. We conclude that decreased expression of TST (or MST) is a tumor marker for CRC. TST expression is increased in colonocyte differentiation. Dysregulation of TST expression and activity resulting in inability to effectively detoxify could be a factor in the cell loss and inflammation that accompany ulcerative colitis and ultimately then in CRC.

colorectal cancer; thiosulfate sulfurtransferase; butyrate; HT-29

This article has been cited by other articles:

				M. Goubern, M. Andriamihaja, T. Nubel, F. Blachier, and F. Bouillaud Sulfide, the first inorganic substrate for human cells FASEB J, June 1, 2007; 21(8): 1699 - 1706. [Abstract] [Full Text] [PDF]